Abstract
Iotrolan 280 was compared with iopamidol 300 for safety and efficacy in peripheral arteriography in a randomized multicenter study of 148 patients. Both contrast agents provided good visualization with no statistical difference, between them. Pain and heat sensations following iotrolan were milder than after iopamidol. Adverse events occurred in three patients receiving iotrolan and four patients receiving iopamidol, with no statistical difference. The clinical value of iotrolan 280 was judged to be better than iopamidol 300 in peripheral arteriography on the basis of reduced pain and heat sensations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
